Viscofan World Viscofan Group (english)

Viscofan Group


Viscofan BioEngineering

Viscofan Group releases January-March 2019 results

​Main highlights of the January-March 2019 results:

>>€201.2 million in revenue, up 7.2% on the previous year.

>>€45.9 million in EBITDA, down 0.8% in recurring terms versus the previous year. Reported EBITDA was down 15.8% when the non-recurring amount of compensation received in 2018 for patent infringement is included.

>>€22.8 million in net profit, down 11.6% in recurring terms. Including non-recurring impact recorded in 2018 Net Profit is down 28.1% on the previous year.

>>€70.0 million in net bank debt in March 2019, down 12.1% on the €79.7 million reported at the end of December 2018.

>>According to José Domingo de Ampuero y Osma, chairman of the Viscofan Group: “Viscofan continues to strengthen its competitive position across the main casings families, within an adverse backdrop of energy costs and wage inflation. The efficiency improvements and the launch of new products exhibited at IFFA trade fair in Germany, will allow us to combine higher volumes of casings with increased production savings in the second half of the year, in line with our growth plans".

You can find all results information on Investors Relations´site. Link

® Viscofan Group